• 1
    Brown ML, Riley GF, Schussler N, Etzioni R. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care 2002; 40 (8 Suppl.): IV104–17
  • 2
    Yabroff KR, Lamont EB, Mariotto A et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst 2008; 100: 63041
  • 3
    Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and quality of life. Ann Rev Public Health 2001; 22: 91113
  • 4
    Warren JL, Brown ML, Fay MP, Schussler N, Potosky AL, Riley GF. Costs of treatment for elderly women with early-stage breast cancer in fee-for-service settings. J Clin Oncol 2002; 20: 30716
  • 5
    Marrett LD, Clarke EA, Hatcher J, Weir HK. Epidemiologic research using the Ontario Cancer Registry. Can J Public Health 1986; 77 (Suppl. 1): 7985
  • 6
    Brown ML, Riley GF, Potosky AL, Etzioni R. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999; 37: 124959
  • 7
    Etzioni R, Riley GF, Ramsey SD, Brown M. Measuring costs: administrative claims data, clinical trials, and beyond. Med Care 2002; 40 (6 Suppl.): III63–72
  • 8
    Riley GF, Potosky AL, Lubitz JD, Kessler LG. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995; 33: 82841
  • 9
    Taplin SH, Barlow W, Urban N et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995; 87: 41726
  • 10
    Etzioni R, Ramsey SD, Berry K, Brown M. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer study. Health Econ 2001; 10: 24556
  • 11
    Ontario Ministry of Health and Long-Term Care. The Health Analyst’s Toolkit. Toronto: Queen’s Printer for Ontario, 2006: 42
  • 12
    Canadian Coordinating Office for Health Technology Assessment. A Guidance Document for the Costing Process, Version 1.0. Ottawa: CADTH, 1996
  • 13
    Canadian Institute of Health Information. Resource Intensity Weights. Summary of Methodology 1995/96. Ottawa: The Institute; 1995: 175
  • 14
    Pink GH, Bolley HB. Physicians in health care management: 3: case mix groups and resource intensity weights: an overview for physicians. Can Med Assoc J 1994; 150: 88994
  • 15
    Earle C, Coyle D, Smith A, Agboola O, Evans WK. The cost of radiotherapy at an Ontario Regional cancer centre: a re-evaluation. Crit Rev Oncol Hemat 1999; 32: 8793
  • 16
    Poon I, Pintilie M, Potvin M, McGowan T. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy. Can J Urol 2004; 11: 212532
  • 17
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 6139
  • 18
    Reid RJ, MacWilliam L, Verhulst L, Roos N, Atkinson M. Performance of the ACG case-mix system in two Canadian provinces. Med Care 2001; 39: 8699
  • 19
    Starfield B, Weiner JP, Mumford L, Steinwachs D. Ambulatory care groups: a categorization of diagnosis for research and management. Health Serv Res 1991; 26: 5374
  • 20
    Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP. Comorbidity: implications for the importance of primary care in ‘case’ management. Ann Fam Med 2003; 1: 814
  • 21
    Starfield B, Lemke KW, Herbert R, Pavlovich WD, Anderson G. Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med 2005; 3: 21522
  • 22
    Kralj B. Measuring ‘rurality’ for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 2000; October: 3352
  • 23
    Cooper GS, Yuan Z, Stange KC, Amini SB, Dennis LK, Rimm AA. The utility of Medicare claims data for measuring cancer stage. Med Care 1999; 37: 70611
  • 24
    Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public datasets. Ann Rev Public Health 2002; 23: 15169
  • 25
    SAS Inc. SAS 9.1 for Windows. Cary, NC: SAS Inc., 20022003
  • 26
    Bondy SJ, Iscoe NA, Rothwell DM et al. Trends in hormonal management of prostate cancer: a population-based study in Ontario. Med Care 2001; 39: 38496
  • 27
    Loblaw DA, Virgo KS, Nam R et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007; 25: 1596605
  • 28
    Alibhai SM, Krahn MD, Cohen MM, Fleshner NE, Tomlinson GA, Naglie G. Is there age bias in the treatment of localized prostate carcinoma? Cancer 2004; 100: 7281
  • 29
    Jayadevappa R, Chhatre S, Weiner M, Bloom BS, Malkowicz B. Medical care cost of patients with prostate cancer. Urol Oncol 2005; 23: 15562
  • 30
    Wilson LS, Tesoro R, Elkin EP et al. Cumulative cost patterns of prostate cancer treatments. Cancer 2007; 109: 51827
  • 31
    Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40 (8 Suppl.): IV3–18
  • 32
    Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care 2007; 45: 1549
  • 33
    Burkhardt JH, Litwin MS, Rose CM et al. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. J Clin Oncol 2002; 20: 286975
  • 34
    Sangar VK, Ragavan N, Matanhelia SS, Watson MW, Blades RA. The economic consequences of prostate cancer and bladder cancer in the UK. BJU Int 2005; 95: 5963
  • 35
    Brandeis J, Pashos CL, Henning JM, Litwin MS. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 2000; 89: 17929
  • 36
    Warren JL, Yabroff R, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 2008; 100: 88897
  • 37
    Lipscomb J. Estimating the cost of cancer in the United States: a work very much in progress. J Natl Cancer Inst 2008; 100: 60710